Table 2.

Treatment-emergent adverse events.

Event	All Patients (n = 91)
Number of adverse events, n	25
Number of serious adverse events, n	0
Number of patients with adverse events, n (%)	21 (23%)
Number of patients with serious adverse events, n (%)	0 (0%)
Number of patients with adverse events leading to treatment discontinuation, n (%)	0 (0%)
*Most frequent any adverse event Constipation, n (%) Dizziness, n (%) Fatigue, n (%) Arthralgia, n (%) Injection site reaction, n (%) Nausea, n (%) Rash, n (%) Weight gain, n (%)	4 (4%) 4 (4%) 3 (3%) 2 (2%) 2 (2%) 2 (2%) 2 (2%) 2 (2%)

^*Adverse events occurring in ≥2% of patients.